Glipizide Tablet, Film Coated, Extended Release
Product Images NDC 68788-8487

3 FDA label images from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 68788-8487). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural-formula (Structural Formula)

Structural-formula (Structural Formula)
Chemical structure of Glipizide displayed as a molecular diagram illustrating atomic connections typical of this oral hypoglycemic agent.*
FDA Label Image
FDA Label Image

Glipizide Extended-release 2.5mg (Label 2.5mg T10.jpg)

Glipizide Extended-release 2.5mg (Label 2.5mg T10.jpg)
Glipizide Extended-Release 2.5 mg tablet label shows the product name and strength prominently. The label indicates it is an extended-release, film-coated oral tablet, generic for Glucotrol XL. It includes manufacturer information (Unique Pharmaceutical Laboratories), storage instructions, and caution on drug transfer. Directions for use are provided in both English and Spanish on a yellow background, with barcode and serialization details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.